Đại học Phan Châu Trinh
Đại học Phan Châu Trinh
Tuyển Sinh Đại Học
Tuyển sinh Đại học 2024
Kết nối với chúng tôi qua Zalo:

Hypothyroidism: Diagnosis and Treatment

Hypothyroidism: Diagnosis and Treatment

STEPHEN A. WILSON, MD, MPH, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts

LEAH A. STEM, MD, MS, and RICHARD D. BRUEHLMAN, MD, University of Pittsburgh Medical Center St. Margaret Family Medicine Residency Program, Pittsburgh, Pennsylvania

Clinical hypothyroidism affects one in 300 people in the United States, with a higher prevalence among female and older patients. Symptoms range from minimal to life-threatening (myxedema coma); more common symptoms include cold intolerance, fatigue, weight gain, dry skin, constipation, and voice changes. The signs and symptoms that suggest thyroid dysfunction are nonspecific and nondiagnostic, especially early in disease presentation; therefore, a diagnosis is based on blood levels of thyroid-stimulating hormone and free thyroxine. There is no evidence that population screening is beneficial. Symptom relief and normalized thyroid-stimulating hormone levels are achieved with levothyroxine replacement therapy, started at 1.5 to 1.8 mcg per kg per day. Adding triiodothyronine is not recommended, even in patients with persistent symptoms and normal levels of thyroid-stimulating hormone. Patients older than 60 years or with known or suspected ischemic heart disease should start at a lower dosage of levothyroxine (12.5 to 50 mcg per day). Women with hypothyroidism who become pregnant should increase their weekly dosage by 30% up to nine doses per week (i.e., take one extra dose twice per week), followed by monthly evaluation and management. Patients with persistent symptoms after adequate levothyroxine dosing should be reassessed for other causes or the need for referral. Early recognition of myxedema coma and appropriate treatment is essential. Most patients with subclinical hypothyroidism do not benefit from treatment unless the thyroid-stimulating hormone level is greater than 10 mIU per L or the thyroid peroxidase antibody is elevated.

Hypothyroidism occurs when there is inadequate thyroid hormone production by the thyroid gland or insufficient stimulation by the hypothalamus or pituitary gland. Causes may include primary gland failure or can be iatrogenic, transient, or central (Table 1).14 Central causes, such as low levels of thyroid-stimulating hormone (TSH) and free thyroxine (FT4), are rare.

Source: https://www.aafp.org/afp/2021/0515/p605.html?cmpid=em_AFP_20210514